Kathryn E. Falberg, EVP and CFO at Jazz Pharmaceuticals plc (JAZZ), sold 3,000 shares at $120.50 ($362K) on 2013-12-11, disclosed to the SEC on 2013-12-13.
Scheduled sale ($362k) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTD | SELL | 2024-03-12 | $16.9M | — | Filing → |
| NUVB | BUY | 2022-12-05 | $789K | — | Filing → |
| TTD | SELL | 2021-11-23 | $32.5M | — | Filing → |